B. Lefebvre

B. Lefebvre, R. Tsang, D. Moore, 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec

B. Lefebvre, P. De Wals, G. Deceuninck, 2017, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch.

B. Lefebvre, P. De Wals, G. De Serres, 2019, Vaccine.

How many individuals with asthma need to be vaccinated to prevent one case of invasive pneumococcal disease?

B. Lefebvre, C. Quach, Julie M Okapuu, 2014, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Characterization of OXA-48-like carbapenemase producers in Canada, 2011–14

P. V. Van Caeseele, B. Lefebvre, L. Hoang, 2018, The Journal of antimicrobial chemotherapy.

Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years.

G. Horsman, B. Lefebvre, L. Hoang, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

The Changing Epidemiology of Meningococcal Disease in Quebec, Canada, 1991–2011: Potential Implications of Emergence of New Strains

B. Lefebvre, P. De Wals, M. Douville-Fradet, 2012, PloS one.

Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada.

B. Lefebvre, P. De Wals, G. Deceuninck, 2012, Vaccine.

Effectiveness of Serogroup C Meningococcal Conjugate Vaccine: A 7-Year Follow-up in Quebec, Canada

B. Lefebvre, P. De Wals, G. De Serres, 2011, The Pediatric infectious disease journal.

Augmentation des infections invasives à Neisseria meningitidis de sérogroupe W au Canada de 2009 à 2016

G. Horsman, B. Lefebvre, F. Jamieson, 2017 .

Increase in Neisseria meningitidis serogroup W invasive disease in Canada: 2009-2016.

G. Horsman, P. V. Van Caeseele, B. Lefebvre, 2017, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Invasive pneumococcal disease surveillance in Canada, 2020

P. V. Van Caeseele, W. Demczuk, I. Martin, 2022, Canada Communicable Disease Report.

Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.

G. Horsman, B. Lefebvre, L. Hoang, 2015, Journal of medical microbiology.

Intestinal mucosa adherence and cytotoxicity of a sorbitol-fermenting, Shiga-toxin-negative Escherichia coli O157:NM isolate with an atypical type III secretion system.

B. Lefebvre, F. Malouin, M. Diarra, 2010, Foodborne pathogens and disease.

Genotype comparison of sorbitol-negative Escherichia coli isolates from healthy broiler chickens from different commercial farms.

B. Lefebvre, F. Malouin, M. Diarra, 2009, Poultry science.

Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.

P. V. Van Caeseele, G. Van Domselaar, B. Lefebvre, 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada

B. Lefebvre, P. De Wals, J. Longtin, 2017, Open Forum Infectious Diseases.

Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.

B. Lefebvre, P. De Wals, M. Douville-Fradet, 2014, Vaccine.

Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets

B. Lefebvre, P. De Wals, R. Tsang, 2015, BMC Microbiology.

Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.

B. Lefebvre, P. De Wals, J. Longtin, 2018, Vaccine.

Detection of virulence-associated genes in Escherichia coli O157 and non-O157 isolates from beef cattle, humans, and chickens.

B. Lefebvre, F. Malouin, M. Diarra, 2008, Journal of food protection.

Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

P. V. Van Caeseele, B. Lefebvre, L. Hoang, 2019, Canada communicable disease report = Releve des maladies transmissibles au Canada.

A Novel Plasmid, pSx1, Harboring a New Tn1696 Derivative from Extensively Drug-Resistant Shewanella xiamenensis Encoding OXA-416.

B. Lefebvre, M. Walker, S. Bekal, 2017, Microbial drug resistance.

Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012-2016.

P. V. Van Caeseele, I. Martin, B. Lefebvre, 2019, Canada communicable disease report = Releve des maladies transmissibles au Canada.

A Side by Side Comparison of Bruker Biotyper and VITEK MS: Utility of MALDI-TOF MS Technology for Microorganism Identification in a Public Health Reference Laboratory

M. Domingo, S. Lévesque, C. Tremblay, 2015, PloS one.

Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1.

P. V. Van Caeseele, B. Lefebvre, L. Hoang, 2014, The Journal of antimicrobial chemotherapy.

Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae

P. V. Van Caeseele, W. Demczuk, I. Martin, 2021, Antimicrobial agents and chemotherapy.

Enterobacter cloacae Complex Isolates Harboring blaNMC-A or blaIMI-Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and Plasmids

B. Lefebvre, L. Hoang, M. Mulvey, 2017, Antimicrobial Agents and Chemotherapy.

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

B. Lefebvre, P. De Wals, G. De Serres, 2016, Vaccine.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

M. Gilmour, W. Demczuk, I. Martin, 2012, Canadian journal of microbiology.

Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain

W. Demczuk, I. Martin, B. Lefebvre, 2018, Emerging infectious diseases.

Emergence and Characterization of Neisseria gonorrhoeae Isolates With Decreased Susceptibilities to Ceftriaxone and Cefixime in Canada: 2001–2010

M. Gilmour, I. Martin, B. Lefebvre, 2012, Sexually transmitted diseases.

Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada

G. Horsman, I. Martin, B. Lefebvre, 2016, Emerging infectious diseases.

Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2020

Samir N. Patel, B. Lefebvre, L. Hoang, 2022, Canada Communicable Disease Report.

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017

W. Demczuk, I. Martin, B. Lefebvre, 2018, Emerging infectious diseases.

Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples.

W. Demczuk, I. Martin, S. Peterson, 2020, The Journal of antimicrobial chemotherapy.

Growth performance and shedding of some pathogenic bacteria in feedlot cattle treated with different growth-promoting agents.

B. Lefebvre, F. Malouin, M. Diarra, 2006, Journal of food protection.

Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae

G. Horsman, W. Demczuk, I. Martin, 2015, Journal of Clinical Microbiology.

Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.

M. Gilmour, P. V. Van Caeseele, W. Demczuk, 2018, The Journal of antimicrobial chemotherapy.

vanA-containing Enterococcus faecium susceptible to vancomycin and teicoplanin because of major nucleotide deletions in Tn1546.

S. Lévesque, B. Lefebvre, A. Bourgault, 2011, The Journal of antimicrobial chemotherapy.

Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010

B. Lefebvre, P. De Wals, J. Proulx, 2014, International journal of circumpolar health.

Whole Genome Sequencing to study the phylogenetic structure of serotype a Haemophilus influenzae recovered from patients in Canada.

G. Van Domselaar, B. Lefebvre, L. Hoang, 2020, Canadian journal of microbiology.

Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis

B. Lefebvre, P. De Wals, C. Quach, 2023, Lancet regional health. Americas.

A Comparison of Real-Time Polymerase Chain Reaction Assays for the Detection of Antimicrobial Resistance Markers and Sequence Typing From Clinical Nucleic Acid Amplification Test Samples and Matched Neisseria gonorrhoeae Culture

W. Demczuk, I. Martin, S. Peterson, 2018, Sexually transmitted diseases.

Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens

G. Horsman, W. Demczuk, I. Martin, 2015, Journal of Clinical Microbiology.

Carbapenem-hydrolyzing Oxacillinase-48 and Oxacillinase-181 in Canada, 2011

Mark A. Miller, B. Lefebvre, L. Hoang, 2013, Emerging infectious diseases.

Relative cytotoxicity of Escherichia coli O157:H7 isolates from beef cattle and humans.

C. Vincent, B. Lefebvre, F. Malouin, 2009, Foodborne pathogens and disease.

B. Lefebvre, P. De Wals, R. Tsang, 2015, BMC Microbiology.

Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020.

P. V. Van Caeseele, W. Demczuk, I. Martin, 2023, The Journal of antimicrobial chemotherapy.

Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018

P. V. Van Caeseele, W. Demczuk, I. Martin, 2022, Antimicrobial agents and chemotherapy.

Enterobacter sp. N18-03635 harbouring blaFRI-6 class A carbapenemase, Canada.

B. Lefebvre, M. Mulvey, D. Boyd, 2019, The Journal of antimicrobial chemotherapy.

Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012

P. V. Van Caeseele, I. Martin, B. Lefebvre, 2015, Journal of Clinical Microbiology.

Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants

W. Demczuk, I. Martin, B. Lefebvre, 2019, Antimicrobial Agents and Chemotherapy.

Carbapenem Non-Susceptible Enterobacteriaceae in Quebec, Canada: Results of a Laboratory Surveillance Program (2010–2012)

S. Lévesque, C. Tremblay, B. Lefebvre, 2015, PloS one.

Correlates of Neisseria gonorrhoeae antimicrobial resistance: cross-sectional results from an open cohort sentinel surveillance network in Québec, Canada, 2016–2019

B. Lefebvre, A. Labbé, F. Defay, 2023, BMJ open.

Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010.

M. Gilmour, G. Horsman, I. Martin, 2013, Canadian journal of microbiology.

Arrival of the rare carbapenemase OXA-204 in Canada causing a multispecies outbreak over 3 years.

B. Lefebvre, M. Mulvey, A. Ruest, 2020, The Journal of antimicrobial chemotherapy.

Population genetics of Haemophilus influenzae serotype a in three Canadian provinces.

B. Lefebvre, L. Hoang, J. Wylie, 2013, Canadian journal of microbiology.